Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoides.
Saleh MN, LeMaistre CF, Kuzel TM, Foss F, Platanias LC, Schwartz G, Ratain M, Rook A, Freytes CO, Craig F, Reuben J, Sams MW, Nichols JC. Saleh MN, et al. Among authors: kuzel tm. J Am Acad Dermatol. 1998 Jul;39(1):63-73. doi: 10.1016/s0190-9622(98)70403-7. J Am Acad Dermatol. 1998. PMID: 9674399 Clinical Trial.
Novel treatment approaches for cutaneous T-cell lymphoma.
Foss FM, Kuzel TM. Foss FM, et al. Among authors: kuzel tm. Cancer Treat Res. 1999;99:227-40. doi: 10.1007/978-0-585-38571-6_9. Cancer Treat Res. 1999. PMID: 9891869 Review. No abstract available.
Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma.
Olsen E, Duvic M, Frankel A, Kim Y, Martin A, Vonderheid E, Jegasothy B, Wood G, Gordon M, Heald P, Oseroff A, Pinter-Brown L, Bowen G, Kuzel T, Fivenson D, Foss F, Glode M, Molina A, Knobler E, Stewart S, Cooper K, Stevens S, Craig F, Reuben J, Bacha P, Nichols J. Olsen E, et al. J Clin Oncol. 2001 Jan 15;19(2):376-88. doi: 10.1200/JCO.2001.19.2.376. J Clin Oncol. 2001. PMID: 11208829 Clinical Trial.
243 results